Apollo Hospitals Hits Record High After Macquarie Upgrade
APOLLOHOSP Enterprise Ltd shares surged nearly 5.3% on November 20, 2026, hitting a fresh all-time high of ₹9,205. The rally came after global brokerage firm Macquarie upgraded the stock to 'Outperform' from 'Underperform' and sharply raised its target price to ₹10,500 from ₹6,230, indicating potential upside of around 20.2% from the previous closing price. The company also reported strong Q2 FY27 financial performance, with net profit rising 33.6% year-on-year to ₹660 crore, while revenue increased 23% to ₹7,615 crore. EBITDA grew 28.8% to ₹1,191 crore, supported by improved hospital occupancy and higher patient volumes. The brokerage remains positive on Apollo's growth prospects, citing improving profitability and expansion of hospital capacity. However, rising expansion costs and potential regulatory changes in oncology drug pricing remain key risks for investors to monitor.



















